163 related articles for article (PubMed ID: 10971497)
1. Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK.
Ravenscroft JC; Layton A; Barnham M
Clin Exp Dermatol; 2000 Jun; 25(4):327-30. PubMed ID: 10971497
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus.
Afset JE; Maeland JA
Scand J Infect Dis; 2003; 35(2):84-9. PubMed ID: 12693555
[TBL] [Abstract][Full Text] [Related]
3. Fusidic acid resistance in Staphylococcus aureus.
Dobie D; Gray J
Arch Dis Child; 2004 Jan; 89(1):74-7. PubMed ID: 14709515
[TBL] [Abstract][Full Text] [Related]
4. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.
Williamson DA; Monecke S; Heffernan H; Ritchie SR; Roberts SA; Upton A; Thomas MG; Fraser JD
Clin Infect Dis; 2014 Nov; 59(10):1451-4. PubMed ID: 25139961
[TBL] [Abstract][Full Text] [Related]
5. Oral fusidic acid fails to eradicate methicillin-resistant Staphylococcus aureus colonization and results in emergence of fusidic acid-resistant strains.
Chang SC; Hsieh SM; Chen ML; Sheng WH; Chen YC
Diagn Microbiol Infect Dis; 2000 Feb; 36(2):131-6. PubMed ID: 10705056
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus aureus resistant to fusidic acid among Swedish children: a follow-up study.
Osterlund A; Kahlmeter G; Haeggman S; Olsson-Liljequist B;
Scand J Infect Dis; 2006; 38(5):334-4. PubMed ID: 16724423
[TBL] [Abstract][Full Text] [Related]
7. High levels of fusidic acid-resistant Staphylococcus aureus despite restrictions on antibiotic use.
Mitra A; Mohanraj M; Shah M
Clin Exp Dermatol; 2009 Mar; 34(2):136-9. PubMed ID: 18828847
[TBL] [Abstract][Full Text] [Related]
8. Fusidic acid resistance in community isolates of methicillin susceptible Staphylococcus aureus and the use of topical fusidic acid: a retrospective case-control study.
Mason BW; Howard AJ
Int J Antimicrob Agents; 2004 Mar; 23(3):300-3. PubMed ID: 15164973
[TBL] [Abstract][Full Text] [Related]
9. Survey, characterization and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthen area.
El-Zimaity D; Kearns AM; Dawson SJ; Price S; Harrison GA
J Antimicrob Chemother; 2004 Aug; 54(2):441-6. PubMed ID: 15269197
[TBL] [Abstract][Full Text] [Related]
10. Genomic analysis reveals different mechanisms of fusidic acid resistance in Staphylococcus aureus from Danish atopic dermatitis patients.
Edslev SM; Clausen ML; Agner T; Stegger M; Andersen PS
J Antimicrob Chemother; 2018 Apr; 73(4):856-861. PubMed ID: 29253168
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data.
Rennie RP
J Cutan Med Surg; 2006; 10(6):277-80. PubMed ID: 17241597
[TBL] [Abstract][Full Text] [Related]
12. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates.
Yu F; Liu Y; Lu C; Lv J; Qi X; Ding Y; Li D; Huang X; Hu L; Wang L
BMC Microbiol; 2015 Oct; 15():210. PubMed ID: 26463589
[TBL] [Abstract][Full Text] [Related]
13. Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema.
Ravenscroft JC; Layton AM; Eady EA; Murtagh MS; Coates P; Walker M; Cove JH
Br J Dermatol; 2003 May; 148(5):1010-7. PubMed ID: 12786834
[TBL] [Abstract][Full Text] [Related]
14. Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic acid prescribing.
Mason BW; Howard AJ; Magee JT
J Antimicrob Chemother; 2003 Apr; 51(4):1033-6. PubMed ID: 12654748
[TBL] [Abstract][Full Text] [Related]
15. Mupirocin-resistant methicillin-resistant Staphylococcus aureus.
Ambler JE; Drabu YJ
J Hosp Infect; 1996 Jan; 32(1):71-82. PubMed ID: 8904376
[No Abstract] [Full Text] [Related]
16. High levels of fusidic acid-resistant Staphylococcus aureus in dermatology patients.
Shah M; Mohanraj M
Br J Dermatol; 2003 May; 148(5):1018-20. PubMed ID: 12786835
[TBL] [Abstract][Full Text] [Related]
17. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
Howden BP; Grayson ML
Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
[TBL] [Abstract][Full Text] [Related]
18. Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.
Whitby M
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S67-71. PubMed ID: 10528788
[TBL] [Abstract][Full Text] [Related]
19. Fusidic acid resistance in Staphylococcus aureus isolates.
Brown EM; Thomas P
Lancet; 2002 Mar; 359(9308):803. PubMed ID: 11888633
[No Abstract] [Full Text] [Related]
20. Introduction: fusidic acid enters the United States.
Moellering RC; Corey GR; Grayson ML
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S467-8. PubMed ID: 21546622
[No Abstract] [Full Text] [Related]
[Next] [New Search]
